InvestSMART

Antisense Therapeutics Limited (ASX: ANP) - Announcements

Current share price for ANP : $0.058 0.003 (4.92%)+

ASX company news and announcements for Antisense Therapeutics Limited (ANP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Antisense Therapeutics Limited (ANP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Antisense Therapeutics Limited (ANP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Antisense Therapeutics Limited (ANP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$52 Change of Director's Interest Notice (MD) 18 Dec 2019 3:29PM $0.087 $0.058 fallen by 33.33%
$52 Change of Director's Interest Notice (GM) 18 Dec 2019 3:26PM $0.087 $0.058 fallen by 33.33%
$52 Appendix 3B 18 Dec 2019 3:23PM $0.087 $0.058 fallen by 33.33%
$52 Reinstatement to Official Quotation 17 Dec 2019 10:23AM $0.082 $0.058 fallen by 29.27%
$52 Positive results reaffirm plans to advance ATL1102 to P2b 17 Dec 2019 10:23AM $0.082 $0.058 fallen by 29.27%
$52 Antisense Therapeutics - Underwriting of Listed Options 17 Dec 2019 10:08AM $0.082 $0.058 fallen by 29.27%
$52 Change of Director's Interest Notice - RM 16 Dec 2019 11:59AM $0.082 $0.058 fallen by 29.27%
$52 Appendix 3B 16 Dec 2019 11:53AM $0.082 $0.058 fallen by 29.27%
$52 Suspension from Official Quotation 16 Dec 2019 9:53AM $0.082 $0.058 fallen by 29.27%
$52 Clarification of the Trading Halt 12 Dec 2019 1:02PM $0.082 $0.058 fallen by 29.27%
$52 Trading Halt 12 Dec 2019 9:27AM $0.082 $0.058 fallen by 29.27%
$52 Results of Meeting 11 Dec 2019 5:24PM $0.082 $0.058 fallen by 29.27%
$52 AGM Presentation 2019 11 Dec 2019 2:10PM $0.082 $0.058 fallen by 29.27%
$52 Change of Director's Interest Notice - Robert Moses 4 Dec 2019 9:24AM $0.077 $0.058 fallen by 24.68%
$52 Appendix 3B 4 Dec 2019 9:07AM $0.077 $0.058 fallen by 24.68%
$52 Appendix 3B 25 Nov 2019 4:27PM $0.086 $0.058 fallen by 32.56%
$52 Dosing completed in ATL1102 Phase II DMD trial 20 Nov 2019 9:21AM $0.089 $0.058 fallen by 34.83%
$52 Additional ATL1102 trial data presented at DMD UK conference 18 Nov 2019 9:15AM $0.100 $0.058 fallen by 42%
$52 Expiry of Listed Options 15 Nov 2019 5:28PM $0.100 $0.058 fallen by 42%
$52 Change in substantial holding from AEF 14 Nov 2019 12:15PM $0.110 $0.058 fallen by 47.27%
$52 Antisense Therapeutics Listed Option ANPOB Exercise 13 Nov 2019 5:28PM $0.105 $0.058 fallen by 44.76%
$52 Appendix 3B 12 Nov 2019 1:41PM $0.105 $0.058 fallen by 44.76%
$52 Notice of Annual General Meeting/Proxy Form 11 Nov 2019 9:41AM $0.105 $0.058 fallen by 44.76%
$52 Change in substantial holding from AEF 6 Nov 2019 5:43PM $0.110 $0.058 fallen by 47.27%
$52 Appendix 4G 31 Oct 2019 11:35AM $0.095 $0.058 fallen by 38.95%

251 - 275 of 707 results

Page 11 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.